Site Search
410 result(s) found for “ adaptive therapy”
-
Moffitt Cancer Center Announces Research Alliance With Takeda To Advance Cancer Therapies
New collaboration aims to expand clinical and translational research in blood cancers and solid tumors
-
New Two-year Data Show 39 Percent of Non-Hodgkin Lymphoma Patients Treated with CAR T-cell Therapy Remain in Remission
New Two-year Data Show 39 Percent of Non-Hodgkin Lymphoma Patients Tre Frederick Locke, .D. Vice Chair, Blood and Marrow Transplant and Cellular...
-
19MA038N Math Model: A Diagnostic that Predicts Treatment Outcome and Personalize CAR-T Therapies
Math Model: A Diagnostic that Predicts Treatment Outcome and Personali FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICEThe...
-
For These 2 Team Members, the Hope Behind Cell Therapies Is Personal
Alexander Dojcinovski and Jasmine Cherry are both now cancer free and working to cure others
-
Stem Cell and CAR T Therapies Are Giving New Hope for Autoimmune Diseases
Autoimmune patients have new reasons for hope. Learn how stem cell and CAR T therapies at Moffitt Cancer Center are changing treatment for MS and...
-
Moffitt Cancer Center Announces Strategic Collaboration with AstraZeneca to Accelerate Oncology Cell Therapies
The collaboration will leverage Moffitt's clinical expertise to help accelerate the development of AstraZeneca's cell therapy pipeline and enhance...
-
New FDA-Approved Gene-Editing Therapies for Sickle Cell Disease are ‘Game Changers’
Some sickle cell patients receive blood and marrow transplants at Moffitt Cancer Center
-
Moffitt Cancer Center and cTRL Therapeutics Partner To Develop Next-Generation Cell Therapies for Cancer Patients
The collaboration aims to revolutionize solid tumor treatment with minimally invasive, blood-based cell therapies
-
Dr. Ahmed Tests the Response of Systemic Therapies or Radiation Across Different Metastatic Disease Sites
Study presented at 2022 ASTRO presents outcomes of systemic therapies or radiation across various metastatic disease sites.
-
Moffitt Researchers Unlock Immune Cell Contributions that Could Lead to New Therapies for Endometrial Cancer
IgA interactions with pIgR govern anti-tumor activity and are associated with improved outcomes